Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Open-Labeled Randomized Study of Rituximab Versus Standard of Care, for Treatment of Acute Allograft Rejection in Pediatric Renal Transplantation

NCT00697996 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00697996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00697996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Open-Labeled Randomized Study of Rituximab Versus Standard of Care, for Treatment of Acute Allograft Rejection in Pediatric Renal Transplantation
Lead sponsor
Stanford University
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2005
Completion date
August 31, 2007
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation